E
BioAge Labs, Inc. BIOA
$4.51 -$0.10-2.17% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -66.79% 38.81% 9.73% -72.35% -4.53%
Total Depreciation and Amortization 56.76% -21.28% 23.68% -22.45% 48.48%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 8.59% 29.55% 7.02% 30.75% -15.05%
Change in Net Operating Assets 76.27% -155.46% 117.97% 258.27% 16.23%
Cash from Operations -15.01% -237.93% 65.59% 5.39% -0.70%
Capital Expenditure 62.68% -1,538.46% 91.48% -771.43% --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 80.04% -- -- -- --
Cash from Investing 79.94% -299,853.85% 91.48% -771.43% --
Total Debt Issued -- -- -- -- --
Total Debt Repaid 0.00% 0.00% 0.00% 0.00% 0.00%
Issuance of Common Stock -- -- -85.76% 45,914.69% 13,966.67%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -100.00% -- -100.00%
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- 51.04% -94.12% -160.76%
Cash from Financing 0.00% -106.02% -86.94% 8,088.40% -101.42%
Foreign Exchange rate Adjustments -283.33% -108.76% 336.21% -241.18% -189.47%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 61.64% -587.36% -88.67% 1,062.62% -111.96%